Tate & Lyle Dirección

Dirección controles de criterios 3/4

El CEO de Tate & Lyle es Nick Hampton , nombrado en Apr 2018, tiene una permanencia de 6.58 años. compensación anual total es £2.59M, compuesta por 28% salario y 72% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.39% de las acciones de la empresa, por valor de €15.30M. La antigüedad media del equipo directivo y de la junta directiva es de 6.2 años y 3.7 años, respectivamente.

Información clave

Nick Hampton

Chief Executive Officer (CEO)

UK£2.6m

Compensación total

Porcentaje del salario del CEO	28.0%
Permanencia del CEO	6.6yrs
Participación del CEO	0.4%
Permanencia media de la dirección	6.2yrs
Promedio de permanencia en la Junta Directiva	3.7yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Nick Hampton en comparación con los beneficios de Tate & Lyle?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	UK£155m
Jun 30 2024	n/a	n/a	UK£167m
Mar 31 2024	UK£3m	UK£723k	UK£179m
Sep 30 2023	n/a	n/a	UK£165m
Jun 30 2023	n/a	n/a	UK£146m
Mar 31 2023	UK£3m	UK£712k	UK£127m
Sep 30 2022	n/a	n/a	UK£70m
Jun 30 2022	n/a	n/a	UK£48m
Mar 31 2022	UK£2m	UK£685k	UK£26m
Sep 30 2021	n/a	n/a	UK£56m
Jun 30 2021	n/a	n/a	UK£73m
Mar 31 2021	UK£3m	UK£665k	UK£89m
Dec 31 2020	n/a	n/a	UK£124m
Sep 30 2020	n/a	n/a	UK£159m
Jun 30 2020	n/a	n/a	UK£202m
Mar 31 2020	UK£2m	UK£665k	UK£245m
Dec 31 2019	n/a	n/a	UK£238m
Sep 30 2019	n/a	n/a	UK£231m
Jun 30 2019	n/a	n/a	UK£206m
Mar 31 2019	UK£3m	UK£665k	UK£181m
Sep 30 2018	n/a	n/a	UK£220m
Jun 30 2018	n/a	n/a	UK£242m
Mar 31 2018	UK£3m	UK£526k	UK£263m

Compensación vs. Mercado: La compensación total de Nick($USD3.26M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD1.92M).

Compensación vs. Ingresos: La compensación de Nick ha sido consistente con los resultados de la empresa en el último año.

CEO

Nick Hampton (57 yo)

6.6yrs

Permanencia

UK£2,585,000

Compensación

Mr. Anthony Nicholas Seymour Hampton, also known as Nick, MA (Hons), has been Chief Executive of Tate & Lyle plc since April 1, 2018 and has been its Director since September 2014. He joined Tate & Lyle pl...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Anthony Nicholas Hampton	CEO & Executive Director	6.6yrs	UK£2.59m	0.39% € 15.3m
Sarah Kuijlaars	CFO & Director	less than a year	sin datos	0.0045% € 175.1k
Melissa Law	President of Global Operations	7.2yrs	sin datos	0.015% € 573.3k
Christopher Marsh	Vice President of Investor Relations	no data	sin datos	sin datos
Lindsay Beardsell	Executive VP & General Counsel	6.2yrs	sin datos	sin datos
Tamsin Vine	Chief Human Resources Officer	1.9yrs	sin datos	sin datos
Rowan Adams	Executive Vice President of Corporate Affairs	10yrs	sin datos	0.057% € 2.2m
Andrew Taylor	President of Asia	7.2yrs	sin datos	sin datos
Victoria Grant	President of Innovation & Commercial Development	4yrs	sin datos	sin datos
Kavita Karnik	Global Head of Nutrition	no data	sin datos	sin datos
William Magee	President of North America	3.1yrs	sin datos	0.0052% € 204.4k
Jan-Jaap Der Bij	Senior Vice President of Global Environment	no data	sin datos	sin datos

6.2yrs

Permanencia media

53.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TLYB es experimentado (6.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Anthony Nicholas Hampton	CEO & Executive Director	10.2yrs	UK£2.59m	0.39% € 15.3m
Sarah Kuijlaars	CFO & Director	less than a year	sin datos	0.0045% € 175.1k
Lars Frederiksen	Independent Non-Executive Director	8.6yrs	UK£69.00k	0.0029% € 112.6k
Warren Tucker	Independent Non-Executive Director	6yrs	UK£183.00k	0.0022% € 87.2k
Kimberly Nelson	Lead Independent Non-Executive Director	5.3yrs	UK£72.00k	0.0013% € 48.9k
Jeffrey Carr	Independent Non-Executive Director	less than a year	sin datos	0.0022% € 87.5k
Glenn Fish	Director	no data	sin datos	sin datos
David Lovat Hearn	Independent Chairman	less than a year	UK£89.00k	0.0043% € 166.9k
Sybella Stanley	Independent Non-Executive Director	8.6yrs	UK£84.00k	0.00096% € 37.5k
Patricia Corsi	Independent Non-Executive Director	3.5yrs	UK£69.00k	sin datos
Isabelle Esser	Independent Non-Executive Director	2.4yrs	UK£69.00k	sin datos
Kwok Cheung	Independent Non-Executive Director	3.8yrs	UK£69.00k	0.0011% € 43.8k

3.7yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de TLYB se considera experimentada (3.7 años de antigüedad promedio).

Tate & Lyle Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Tate & Lyle plc Announces Board Changes

Tate & Lyle plc Announces Company Secretary Changes

Tate & Lyle plc, Annual General Meeting, Jul 25, 2024

High number of new directors

Tate & Lyle plc Announces Resignation of Dawn Allen, Chief Financial Officer

Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024

Recent updates

First half dividend of UK£0.064 announced

First half 2025 earnings released: EPS: UK£0.18 (vs UK£0.26 in 1H 2024)

Tate & Lyle Surges on Takeover Talk

Investor sentiment improves as stock rises 19%

Tate & Lyle plc Announces Board Changes

Tate & Lyle plc Announces Company Secretary Changes

KPS Capital Partners, LP completed the acquisition of remaining 49.7% stake in Primary Products Investments LLC from Tate & Lyle plc (LSE:TATE).

Tate & Lyle plc (LSE:TATE) announces an Equity Buyback for £215 million worth of its shares.

Upcoming dividend of UK£0.13 per share

Tate & Lyle plc, Annual General Meeting, Jul 25, 2024

Full year 2024 earnings released: EPS: UK£0.45 (vs UK£0.31 in FY 2023)

First half dividend of UK£0.13 announced

Tate & Lyle plc Recommends Final Dividend for the Year 2024, Payable on August 2, 2024

High number of new directors

Tate & Lyle plc Announces Resignation of Dawn Allen, Chief Financial Officer

Tate & Lyle plc(LSE:TATE) dropped from FTSE All-World Index (USD)

Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024

Tate & Lyle plc Provides Revenue Guidance for the Year Ending 31 March 2024

Tate & Lyle plc to Report Q2, 2025 Results on Nov 07, 2024

Tate & Lyle plc to Report First Half, 2025 Results on Nov 09, 2024

Upcoming dividend of UK£0.062 per share at 2.9% yield

Tate & Lyle plc Declares an Interim Dividend

First half 2024 earnings released: EPS: UK£0.26 (vs UK£0.14 in 1H 2023)

Tate & Lyle plc Announces Directorate Changes

Tate & Lyle plc Announces Appointment of Warren Tucker as Interim Chairman to the Board

Tate & Lyle plc to Report Q2, 2024 Results on Nov 09, 2023

Tate & Lyle plc Announces Directorate Change

Upcoming dividend of UK£0.13 per share at 2.5% yield

Tate & Lyle plc, Annual General Meeting, Jul 27, 2023

Now 22% undervalued

Full year 2023 earnings released: EPS: UK£0.31 (vs UK£0.065 in FY 2022)

Tate & Lyle plc Recommends Final Dividend, Payable on 2 August 2023

Tate & Lyle plc to Report Fiscal Year 2023 Results on May 25, 2023

Tate & Lyle plc Reaffirms Earnings Guidance for the Year Ending 31 March 2023

Upcoming dividend of UK£0.054 per share

First half 2023 earnings released: EPS: UK£0.14 (vs UK£0.03 in 1H 2022)

First half 2023 earnings released: EPS: UK£0.14 (vs UK£0.03 in 1H 2022)

Tate & Lyle plc Approves Interim Dividend for the Six Months to 30 September 2022, Payable on 4 January 2023

Tate & Lyle plc to Report First Half, 2023 Results on Nov 10, 2022

Tate & Lyle plc to Report First Half, 2023 Results on Nov 10, 2022

High number of new directors

High number of new directors

Upcoming dividend of UK£0.13 per share

Tate & Lyle plc, Annual General Meeting, Jul 28, 2022

Now 20% undervalued after recent price drop

Full year 2022 earnings released

Tate & Lyle plc (LSE:TATE) completed the acquisition of Guangdong Quantum Hi-Tech Microecology Medical Co., Ltd. from Chempartner Pharmatech Co., Ltd. (SZSE:300149).

Tate & Lyle plc Proposes Final Dividend for the Financial Year 2022, Payable on 5 August 2022

Upcoming dividend of UK£1.07 per share

Tate & Lyle plc, Annual General Meeting, Apr 26, 2022

Tate & Lyle plc (LSE:TATE) signed an agreement to acquire Guangdong Quantum Hi-Tech Microecology Medical Co., Ltd. from Chempartner Pharmatech Co., Ltd. (SZSE:300149) for $237 million.

Tate & Lyle plc to Report Fiscal Year 2022 Results on Jun 09, 2022

Tate & Lyle plc Appoints Dawn Allen to the Position of Chief Financial Office, Effective from May 16, 2022

Tate & Lyle plc (LSE:TATE) acquired an unknown minority stake in Zymtronix Catalytic Systems Inc.

Upcoming dividend of UK£0.09 per share

First half 2022 earnings released: EPS UK£0.026 (vs UK£0.097 in 1H 2021)

Independent Non-Executive Chairman recently bought €80k worth of stock

Independent Non Executive Director Anne Minto has left the company

Full year 2021 earnings released: EPS UK£0.55 (vs UK£0.53 in FY 2020)

Upcoming dividend of UK£0.22 per share

Full year 2021 earnings released: EPS UK£0.55 (vs UK£0.53 in FY 2020)

Tate & Lyle plc Recommends Final Dividend for the Full Year 2021

Tate & Lyle Exploring Separation of Two Businesses

Independent Non-Executive Director & Chairman of Research Advisory Group Ajai Puri has left the company

CFO & Director has left the company

Tate & Lyle plc, Annual General Meeting, Jul 29, 2021

Ajai Puri to Retire from the Tate & Lyle PLC's Board on 31 March 2021

New 90-day high: €8.50

Tate & Lyle plc (LSE:TATE) completed the acquisition of 85% shareholding in Chaodee Modified Starch Co., Ltd.